Riskpilot← Back to searchSign inGet full accessHandelshuset Viroderm AB
ABActiveOrg 5565360590Fabriksvägen 5Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19961-4 employees
Revenue 2025
SEK 15M
-8% vs 2024
EBITDA margin
18.3%
-17% vs 2024
Equity ratio
82.2%
Financial strength
Net profit 2025
SEK 551K
+137% vs 2024
| Revenue | SEK 15M | -8% |
| EBITDA | SEK 2,7M | -17% |
| Net profit | SEK 551K | +137% |
| Total assets | SEK 17M | +0% |
| Equity | SEK 13,9M | +0% |
| Employees | — | — |
Legal name
Handelshuset Viroderm AB
Org number
5565360590
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21 november 1996
Share capital
SEK 200 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva marknadsföring och försäljning av kemisk- tekniska och medicintekniska produkter samt därmed förenlig verksamhet. Bolaget skall också göra investeringar i andelar av onoterad bolag samt förvaltning av kapital i bolaget genom därmed förenlig verksamhet.
Address
Fabriksvägen 5
Phone
+468373712
Email
martin@viroderm.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 12 962 | 12 736 | 14 012 | 16 305 | 14 984 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 223 | 1 610 | 2 373 | 3 302 | 2 738 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 2 223 | 1 610 | 2 373 | 3 302 | 2 738 |
| Net financials | 916 | 308 | −3 460 | −8 452 | −3 568 |
| Profit before tax | 3 464 | 1 919 | 663 | −730 | 1 245 |
| Tax | −641 | −403 | −505 | −759 | −694 |
| Net profit | 2 823 | 1 516 | 158 | −1 489 | 551 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 17 085 | 18 301 | 17 397 | 16 956 | 16 964 |
| Equity | 15 179 | 16 219 | 15 887 | 13 898 | 13 949 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 311 | 1 486 | 914 | 2 459 | 2 416 |
| Total debt | 1 311 | 1 486 | 914 | 2 459 | 2 416 |
EBITDA margin
18.3%
This company
15.8%
Market median
+16% vs market
20212025
Equity ratio
82.2%
This company
38.2%
Market median
+115% vs market
20212025
Return on equity
4.0%
This company
18.4%
Market median
-78% vs market
20212025
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
20212025
Asset turnover
0.88×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2022 | |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Handelshuset Viroderm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Jonny Carl Råstedt Törnskog | Audit | 0 companies |
| Rolf Martin von Essen | Board of Directors | 0 companies |
| Sven Peter Englund | Deputy Board Member | 0 companies |
| Solveig Anna Birgitta von Essen | Deputy Board Member | 0 companies |